42 results
8-K
EX-10.6
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
) promptly payable in United States dollars free of any tax, deduction or offset (with respect to monetary awards). Subject to the Appeal Right, any … , or accountings presented or pleaded in the Arbitration, and (d) be promptly payable in United States dollars free of any tax, deduction or offset
8-K
EX-10.2
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
to the arbitrator, and (c) promptly payable in United States dollars free of any tax, deduction or offset (with respect to monetary awards). Subject … , deduction or offset (with respect to monetary awards). Any costs or fees, including without limitation attorneys’ fees, incurred in connection
8-K
EX-10.1
wpsat5h y5nipsj
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.2
nf5jx 3lhwv
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
jreavt0zksipmgxd
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
mpb75zj wn65l
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.2
hftudbg
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-99.2
u4r3zuh1d13b7u l1m
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-99.1
340x4l
5 Oct 23
Index to Financial Statements
5:12pm
424B3
1k1bvxge
14 Aug 23
Prospectus supplement
4:30pm